作者：
Yue-Qin,Zhu [1]
;
Li-Li,Wang [2]
;
Zi-Hao,Li [2]
;
Shi-Shun,Qian [2]
;
Zhou,Xu [2]
;
Jin,Zhang [3]
;
Yong-Hu,Song [3]
;
Xue-Sheng,Pan [4]
;
Na,Du [5]
;
Amira,Abou-Elnour [2]
;
Lynn Jia,Tay [2]
;
Jing-Rong,Zhang [2]
;
Meng-Xue,Li [2]
;
Yu-Xian,Shen [6]
;
Yan,Huang [7]
作者单位：
Department of Pharmacy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, China.;Office of Clinical Trial Institution, Anhui Provincial Cancer Hospital, Hefei, 230031, China.
[1]
Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, 230032, China.
[2]
The First Affiliated Hospital of Anhui Medical University, Hefei, 230032, China.
[3]
Department of Immunology, School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, China.
[4]
Department of Pharmacy, Shanghai Songjiang District Central Hospital, Shanghai, 201600, China.
[5]
Department of Pharmacology, School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, China. shenyx@ahmu.edu.cn.
[6]
Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, 230032, China. huangyan_@ahmu.edu.cn.
[7]
DOI
10.1038/s41401-024-01423-4
PMID
39592735
发布时间
2024-11-26
换一批
换一批
